A brain disease that impairs memory, thinking and behavior. It’s the most common form of dementia, characterized by progressive and chronic deterioration of cognitive functions, including memory, thinking and reasoning.
LATEST ARTICLES
-
The Fight Against Alzheimer’s Disease
Our understanding of the pathology behind Alzheimer's disease has increased dramatically in recent years, yet Alzheimer's is the only one of the top 10 causes of death that currently cannot be prevented, cured or even slowed.
-
Why Has Research into Alzheimer's Disease Been So Hard?
Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?
-
Rethinking Alzheimer's
New approaches to one of the world's most complex diseases are aiming to give months and years back to those facing an otherwise uncertain future.
-
From Technology to Treatment: Uncovering Cures for Brain Diseases
The brain is one of the most complex – and most fascinating – organs in the human body, and one that can be impacted by countless diseases and disorders.
RELATED ARTICLES
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
Disrupting Alzheimer's Disease
Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique challenges that make up Alzheimer's research and what the future holds for the 5.7 million Americans living with the disease.
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
Researcher Profile: Eva Kohegyi
Dr. Eva Kohegyi specializes in research for medications in neurologic and psychiatric indications, including the development of treatments for patients with Alzheimer's disease, Tourette's disease, schizophrenia, bipolar disorder and other illnesses of the central nervous system.
Researcher Profile: Ian Reynolds
Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).
Researcher Profile: Matthew Kennedy
Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer's.
Researcher Profile: Darryle Schoepp
Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.
Explore Genomics in Virtual Reality
Every day, within laboratories across the country, biopharmaceutical researchers are pioneering the latest advancements in science and discovery, and working to transform the future of medicine.
Researcher Profile: Dan Skovronsky
A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.
On the Front Lines of Science
In recent years, medical breakthroughs including new drug therapies and early disease monitoring technologies have accelerated rapidly. This has created wide-ranging transformations in patient care.
Brain Awareness Week
For all we have accomplished in neuroscience, our understanding of human brain function and the diseases that affect it remains a tremendous challenge for researchers.
Using Setbacks as Stepping Stones in Alzheimer's Research
Biopharmaceutical researchers are exploring promising, new approaches to treating and preventing Alzheimer's disease.
